Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-06-28 | ScandiDos | ScandiDos erhåller beställningar för 290 000 EUR från Kina | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-28 | ScandiDos | ScandiDos receives orders worth €290 000 from China | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-19 | Penser Access | Penser Access: Historiskt starkt kvartal med dragkraft i Asien - ScandiDos | Pressreleaser | Visa Stäng |
|
||||
2023-06-15 | ScandiDos | ScandiDos AB - Bokslutskommuniké 1 maj 2022 – 30 apr 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-13 | ScandiDos | ScandiDos och IBA Dosimetry fördjupar sin strategiska allians! | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-13 | ScandiDos | ScandiDos and IBA Dosimetry deepen strategic alliance! | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-20 | Penser Access | Penser Access: Omsättningen växer i Q3 - ScandiDos | Pressreleaser | Visa Stäng |
|
||||
2023-03-14 | ScandiDos | ScandiDos receives an order worth €263 000 from China | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-14 | ScandiDos | ScandiDos erhåller order på € 263 000 från Kina | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-08 | ScandiDos | ScandiDos AB - Delårsrapport 1 maj 2022 – 31 jan 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-02-23 | ScandiDos | ScandiDos sees growing demand for patient-specific QA in Chinese market | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
ScandiDos sees growing demand for patient-specific QA in Chinese marketScandiDos, a leading provider of patient-specific quality assurance solutions, is seeing a growing presence in the Chinese market. The company’s Delta4 Family of products is taking market share and the company is seeing a significant increase in product orders, outpacing the demand seen during previous years. Patient-specific quality assurance (QA) is critical in cancer treatments as it improves treatment outcomes and reduces the risk of complications. As cancer treatments become more and more complex, the need for equally advanced QA solutions grows. The Delta4 family of products is well-positioned to meet these changing needs. ScandiDos has seen considerable demand for its products in China in the last two quarters. The growing business is attributed to the increasing need for advanced radiotherapy treatment technologies to handle the booming cancer patient population. Dominated by the Delta4 Phantom+, the Delta4 Family of products has become the preferred choice for more than 100 hospitals in China. ScandiDos is working closely with its distributor HGPT to develop the Chinese market further. This collaboration has helped ScandiDos to establish a strong foothold in the market and demonstrates ScandiDos’ commitment to providing customers world-wide with the highest quality of services. The Chinese market’s potential for future growth, combined with the increasing demand for patient-specific QA solutions, positions ScandiDos for continued success in the coming years. ”We are thrilled to see this growing demand for our products in China,” says Gustaf Piehl, CEO of ScandiDos. “The Delta4 products are well-suited to meet the needs of the Chinese healthcare providers and we are committed to continue to develop and grow in this market. The response from the Chinese market is a promising sign of continued success in the coming years.” |
||||
2022-12-09 | Penser Access | Penser Access: Åter till tillväxt i Q2 - ScandiDos | Analyser | Visa Stäng |
|
||||
2022-12-07 | ScandiDos | ScandiDos AB - Delårsrapport 1 maj 2022 – 31 okt 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-01 | ScandiDos | ScandiDos receives an order of € 377 500 from Japan | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-01 | ScandiDos | ScandiDos får en order på € 377 500 från Japan | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-17 | ScandiDos | KOMMUNIKÉ FRÅN ÅRSSTÄMMA I SCANDIDOS AB (PUBL) | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-18 | ScandiDos | KALLELSE TILL ÅRSSTÄMMA I SCANDIDOS AB (PUBL) | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-16 | Penser Access | Penser Access: Mot fortsatt expansion med stärkta finanser - ScandiDos | Analyser | Visa Stäng |
|
||||
2022-09-13 | ScandiDos | ScandiDos AB - Delårsrapport 1 maj 2022 – 31 jul 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-02 | ScandiDos | ScandiDos’ directed share issue completed | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-02 | ScandiDos | ScandiDos riktade nyemission slutförd | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-30 | ScandiDos | ScandiDos has completed a directed share issue of 4,150,000 shares at a subscription price of SEK 3 per share | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-30 | ScandiDos | ScandiDos har genomfört en riktad nyemission av 4 150 000 aktier till en teckningskurs om 3 kronor per aktie | Analyser | Ladda ner | Visa Stäng |
|